FDA Sends Warning Letter to Abbott Laboratories

CEO SUMMARY: On March 13, 2007, the Food and Drug Administration sent a warning letter to Abbott Laboratories’ Chairman and CEO, Miles D. White. The letter identified nine quality system violations and requested a satisfactory response by August 15, 2007. The warning letter is based on deficiencies identified by FDA inspectors at Abbott’s manufacturing facility …

FDA Sends Warning Letter to Abbott Laboratories Read More »

This post is only available to members.

FDA Sends Warning Letter to Abbott Laboratories

Products manufactured in Irving, Texas, have not met FDA’s CGMP guidelines

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month